PubMed · 3133966
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
D A Watson, D M Musher, R J Hamill. 1988-08-01. Interferon-gamma and polymorphonuclear leukocytes.. https://doi.org/10.7326/0003-4819-109-3-250_2
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
BACKGROUND: A recent study has demonstrated that radiation therapy with single doses of up to 32 Gy has only a minor effect on neutrophilic granulocyte function. In clinical practice, by contrast, fractionated irradiation is applied. Therefore, the aim of the current study was to verify the influence of fractionated radiation therapy on granulocyte function. MATERIAL AND METHODS: Density gradient-purified granulocytes of voluntary healthy donors were used for all experiments. Granulocytes were kept in RPMI 1640 without fetal calf serum, incubated for 48 h and irradiated. Their function was assessed by measuring luminol-enhanced chemiluminescence after stimulation with phorbol myristate acid (PMA). All tests were performed at least five times. RESULTS: Relative changes (any reactive oxygen species [ROS] release before stimulation was defined as being equal to 100%) in ROS release increased after stimulation wit PMA (mean +/- SD): 0 Gy: 785 +/-, 462.2%; 2 Gy: 704.3 +/- 388.1%; 6 Gy: 1,360.3 +/- 710.5%; 12 Gy: 1,119.4 +/- 581.1%; 18 Gy: 1,087.3 +/- 622.4; 6 Gy (3 x 2 Gy): 279.4 +/- 201.1%; 12 Gy (6 x 2 Gy): 278.8 +/- 175.3%; 18 Gy (9 x 2 Gy): 84.2 +/- 41.5%. Comparing relative changes in ROS release after PMA stimulation, the differences between 0, 2, 6, 12, 18 Gy, and 6 Gy (3 x 2 Gy), 12 Gy (6 x 2 Gy), 18 Gy (9 x 2 Gy), and between 6 Gy (3 x 2 Gy), 12 Gy (6 x 2 Gy) and 18 Gy (9 x 2 Gy) proved to be significant (all p < 0.005). CONCLUSION: The study shows, that clinically used fractionated irradiation has an impact on granulocyte function, but contrary to common assumption, it is not to total dose itself but rather the fractionation which influences granulocyte function. This could have a major clinical impact on radiation treatment schemes especially for benign diseases or anti-inflammatory treatment.
All-trans retinoic acid (ATRA) is a potent differentiation agent that is effective therapy in acute promyelocytic leukaemia. Although ATRA is generally well tolerated, some patients develop retinoic acid syndrome. This syndrome is manifested by unexplained fever, weight gain, respiratory distress, interstitial pulmonary infiltrates, pleural and pericardial effusion, episodic hypotension, and acute renal failure. However, if identified early enough, effective therapy can be administered. This chapter discusses the clinical aspects and pathogenesis of retinoic acid syndrome.
The ability of cells to recognize and respond with directed motility to chemoattractant agents is critical to normal physiological function. Neutrophils represent the prototypic chemotactic cell in that they respond to signals initiated through the binding of bacterial peptides and other chemokines to G protein-coupled receptors with speeds of up to 30 microm/min. It has been hypothesized that localized regulation of cytoskeletal dynamics by Rho GTPases is critical to orchestrating cell movement. Using a FRET-based biosensor approach, we investigated the dynamics of Rac GTPase activation during chemotaxis of live primary human neutrophils. Rac has been implicated in establishing and maintaining the leading edge of motile cells, and we show that Rac is dynamically activated at specific locations in the extending leading edge. However, we also demonstrate activated Rac in the retracting tail of motile neutrophils. Rac activation is both stimulus and adhesion dependent. Expression of a dominant-negative Rac mutant confirms that Rac is functionally required both for tail retraction and for formation of the leading edge during chemotaxis. These data establish that Rac GTPase is spatially and temporally regulated to coordinate leading-edge extension and tail retraction during a complex motile response, the chemotaxis of human neutrophils.